CLINICAL_TRIALS
trial_result
· 2026-02-04
Clinical Trial Update: A Study of Guselkumab in Participants With Active Psoriatic Arthritis [Phase 3]
Summary
Phase 3 clinical trial update for guselkumab in active psoriatic arthritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Arthritis, Psoriatic | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-02-04